Frequency and types of spontaneous Hprt lymphocyte mutations in Pms2-deficient mice

Joseph G Shaddock1, Vasily N Dobrovolsky, Roberta A Mittelstaedt

  • 1Division of Genetic and Reproductive Toxicology, National Center for Toxicological Research, US FDA, Jefferson, AR 72079, USA.

Mutation Research
|December 13, 2005
PubMed

Insights

Loss of the Pms2 protein in mice significantly increases mutations in the Hprt gene, particularly frameshift and A:T to G:C transitions. This DNA mismatch repair deficiency may contribute to cancer predisposition.

Area of Science:

  • Genetics
  • Molecular Biology
  • Cancer Research

Background:

  • Deficiencies in DNA mismatch repair (MMR) are linked to neoplasia in humans and rodents.
  • Pms2 is a key protein in the eukaryotic MMR system.

Purpose of the Study:

  • To investigate the impact of Pms2 deficiency on mutation frequency and spectrum.
  • To analyze mutations in the endogenous Hprt gene of lymphocytes from Pms2-deficient mice.

Main Methods:

  • Lymphocytes were isolated from spleens of Pms2(-/-), Pms2(+/-), and Pms2(+/+) mice of various ages.
  • Mutant frequencies of 6-thioguanine-resistant lymphocytes were measured.
  • Hprt cDNA was analyzed by RT-PCR and DNA sequencing to determine mutation types.

Main Results:

  • Pms2(-/-) mice exhibited significantly higher mutant frequencies compared to Pms2(+/+) and Pms2(+/-) mice.
  • The mutational spectrum in Pms2(-/-) mice differed significantly, showing increased strand-slippage frameshift mutations.
  • A:T --> G:C transitions were elevated in Pms2(-/-) mice, suggesting a common feature of MMR deficiency.

Conclusions:

  • Loss of Pms2 protein leads to increased mutation frequencies and altered mutational spectrum.
  • Elevated A:T --> G:C transitions in MMR-deficient mice may contribute to cancer predisposition.
  • Findings highlight the critical role of Pms2 in maintaining genomic stability.